Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial) - For The New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group; Bousmah, Marwân-al-Qays; Nishimwe, Marie Libérée; Tovar-Sanchez, Tamara; Lantche Wandji, Martial; Mpoudi-Etame, Mireille; Maradan, Gwenaëlle; Omgba Bassega, Pierrette; Varloteaux, Marie; Montoyo, Alice; Kouanfack, Charles; Delaporte, Eric; et al. (PharmacoEconomics, 2020)
Keywords: journalArticle